Global in vitro diagnostics revenues by top companies 2017 and 2024

Global top 10 companies based on in vitro diagnostics revenue in 2017 and 2024 (in million U.S. dollars)

Global in vitro diagnostics revenues by top companies 2017 and 2024 As of 2017, Swiss-based pharmaceutical company Roche was the global leader in the in vitro diagnostics (IVD) market, generating over 10 billion U.S. dollars in revenues in this segment. According to projections, Roche will maintain the leading position until 2024, exceeding 14 billion dollars. Roche’s major competitors are Abbott Laboratories and Danaher from the United States. Among the top 10 companies, U.S. company Exact Sciences from Wisconsin is expected to have the most impressive growth, increasing its IVD revenues nearly sevenfold between 2017 and 2024.
What are in vitro diagnostics?

In vitro diagnostics allow for medical professionals to get information about diseases, conditions, and infections. These tests can be conducted within a laboratory and sometimes within a patient's home. IVDs are a large subgroup of medical devices which can range in size from small handheld devices to large complex laboratory instruments. In general, samples derived from the human body are examined ‘in vitro’ – meaning “in the glass” – for purposes of screening, diagnosis, or monitoring. Today, most medical treatments are based on IVD outcomes. IVDs are also essential for the increasing personalization of medical treatments.

Roche Diagnostics

The Roche Group from Switzerland is one of the top global pharmaceutical companies. Nevertheless, the company has also a strong medical device division - Roche Diagnostics – which is mainly represented by in vitro diagnostics. Among the best-known and best-selling diagnostic devices by Roche are devices from the cobas series, used in immunodiagnostics, clinical chemistry, and virology.
Show more

Global top 10 companies based on in vitro diagnostics revenue in 2017 and 2024 (in million U.S. dollars)

Loading statistic...
Expand statistic
20172024*
Roche10,27614,159
Abbott Laboratories5,61610,120
Danaher5,8408,290
Siemens4,7056,036
Thermo Fisher Scientific3,2414,232
Becton Dickinson2,8494,044
Sysmex2,3013,579
bioMérieux2,0913,377
Ortho Clinical Diagnostics1,8002,101
Exact Sciences2661,781
20172024*
Roche10,27614,159
Abbott Laboratories5,61610,120
Danaher5,8408,290
Siemens4,7056,036
Thermo Fisher Scientific3,2414,232
Becton Dickinson2,8494,044
Sysmex2,3013,579
bioMérieux2,0913,377
Ortho Clinical Diagnostics1,8002,101
Exact Sciences2661,781
Download Settings Share
Download started
Please be patient - this may take a moment
As of 2017, Swiss-based pharmaceutical company Roche was the global leader in the in vitro diagnostics (IVD) market, generating over 10 billion U.S. dollars in revenues in this segment. According to projections, Roche will maintain the leading position until 2024, exceeding 14 billion dollars. Roche’s major competitors are Abbott Laboratories and Danaher from the United States. Among the top 10 companies, U.S. company Exact Sciences from Wisconsin is expected to have the most impressive growth, increasing its IVD revenues nearly sevenfold between 2017 and 2024.
What are in vitro diagnostics?

In vitro diagnostics allow for medical professionals to get information about diseases, conditions, and infections. These tests can be conducted within a laboratory and sometimes within a patient's home. IVDs are a large subgroup of medical devices which can range in size from small handheld devices to large complex laboratory instruments. In general, samples derived from the human body are examined ‘in vitro’ – meaning “in the glass” – for purposes of screening, diagnosis, or monitoring. Today, most medical treatments are based on IVD outcomes. IVDs are also essential for the increasing personalization of medical treatments.

Roche Diagnostics

The Roche Group from Switzerland is one of the top global pharmaceutical companies. Nevertheless, the company has also a strong medical device division - Roche Diagnostics – which is mainly represented by in vitro diagnostics. Among the best-known and best-selling diagnostic devices by Roche are devices from the cobas series, used in immunodiagnostics, clinical chemistry, and virology.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
In Vitro Diagnostics
In Vitro Diagnostics

All Information
in one Presentation

In Vitro Diagnostics

Everything On "In Vitro Diagnostics" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "In Vitro Diagnostics"
  • Global overview
  • Top companies
The most important statistics
  • United States
  • Other regional markets
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.